President Trump's recent announcement about leucovorin's label update opens new doors for autism treatment, especially for those with cerebral folate deficiency. But is it the miracle some parents hope for?
The Trump administration's recent approval of leucovorin as an autism treatment has sparked outrage among experts, with many calling for more research and caution in prescribing this unproven drug.
In a remarkable turn of events, 8-year-old Nathaniel Schumann, who was nonverbal, began to speak in full sentences just two weeks after starting a clinical trial for an autism treatment. This development raises hopes for many families.
